CELZ Creative Medical Technology Holdings, Inc. - Common Stock
$1,11
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 7, 2026
52 Haftlık Aralık
$1–$6
9% of range
Analist Derecelendirmesi
BUY
7 analysts
Fiyat Hedefi
$20
+1702% upside
P/E (TTM)
-0.8
ROE
—
Net Kâr Marjı
—
CELZ Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$1.11
Piyasa Değeri
—
P/E (TTM)
-0.8
EPS (TTM)
$-2.52
Gelir (TTM)
$6.0K
Temettü Verimi
—
ROE
—
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$1 – $6
CELZ Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$6.0K
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.52
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
2017-12-31
→
2020-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
CELZ
Akran Ortalaması
P/E (TTM)
-0.8
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
CELZ
Akran Ortalaması
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
CELZ
Akran Ortalaması
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
CELZ
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-45.5%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-59.2%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
-48.4%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
CELZ
Akran Ortalaması
CELZ Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
7 analist
- Güçlü Al 2 28,6%
- Al 4 57,1%
- Tut 1 14,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
1 analist · 2026-08-19
Düşük
$20.00
Yüksek
$20.00
Medyan hedef
$20.00
+1701,8%
Ortalama hedef
$20.00
+1701,8%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.14%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.41 | $-0.40 | -0.01% |
| 31 Mart 2026 | $-0.38 | $-0.40 | 0.02% |
| 31 Aralık 2025 | $-0.73 | $-0.38 | -0.35% |
| 30 Eylül 2025 | $-0.48 | $-0.49 | 0.01% |
| 30 Haziran 2025 | $-0.48 | $-0.64 | 0.16% |
| 31 Mart 2025 | $-0.83 | $-0.53 | -0.30% |
| 31 Aralık 2024 | $-1.12 | $-0.64 | -0.48% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CELZ | — | -0.8 | -45.5% | — | — | — |
| FBLG | — | -0.5 | — | — | — | — |
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
| ALZN | $5M | -0.4 | — | — | -598.1% | — |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | — |
| LIMN | — | — | — | — | — | — |
| ERNA | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Cost of Revenue | $2.2K | $4.4K | $3.6K | $28.5K | $47.9K | $50.6K | $45.5K | $70.4K | $8.0K | $0 | · | · | |
| Gross Profit | $3.8K | $6.6K | $5.4K | $60.1K | $39.8K | $113.9K | $120.0K | $54.0K | $-3.2K | $0 | · | · | |
| R&D Expense | $2M | $2M | $2M | $6M | $109.2K | $0 | $0 | $96.6K | $260.1K | $85.3K | · | · | |
| SG&A Expense | $4M | $3M | $4M | $4M | $3M | $1M | $1M | $1M | $898.5K | $665.0K | · | · | |
| Operating Expenses | $6M | $6M | $6M | $10M | $3M | $1M | $1M | $1M | $1M | $759.7K | $20.8K | $19.4K | |
| Operating Income | $-6M | $-6M | $-6M | $-10M | $-3M | $-1M | $-1M | $-1M | $-1M | $-759.7K | $-20.8K | $-19.4K | |
| Interest Expense | · | · | · | $0 | $4M | $1M | $2M | $1M | $377.6K | $6.4K | · | · | |
| Other Non-op | $147.8K | $250.4K | $333.6K | $100.3K | $22M | $-35M | $-7M | $-13M | $-1M | $-6.4K | · | · | |
| Pretax Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| EPS (Basic) | · | · | · | $-0.93 | $7.37 | $-62.69 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 | $-62.69 | · | · | · | · | · | · | |
| Shares (Basic) | · | · | · | 10,932,035 | 2,605,057 | 579,461 | · | · | · | · | 18,113,750 | 18,113,750 | |
| Shares (Diluted) | 2,382,797 | 1,480,420 | 1,407,632 | 10,932,035 | 3,248,619 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | · | · | $-1M | $-1M | · | $-1M | $-766.1K | $-20.8K | $-19.4K |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | $3M | $8M | $11M | $98.0K | $88.6K | $304.1K | $13.7K | $221.9K | $100 | $954 | |
| Receivables | · | · | · | $0 | $2.5K | $0 | $5.6K | $9.6K | $4.8K | $0 | · | · | |
| Inventory | $0 | $2.2K | $6.6K | $10.2K | $10.9K | $0 | $0 | · | · | · | · | · | |
| Prepaid Expense | $138.8K | $192.7K | $277.2K | $338.1K | $0 | · | · | · | · | · | · | · | |
| Current Assets | $7M | $6M | $10M | $19M | $11M | $98.0K | $94.2K | $313.7K | $18.5K | $221.9K | $49.6K | $954 | |
| Intangibles | $407.2K | $530.6K | $441.0K | $435.6K | $527.7K | $619.8K | $436.6K | $163.5K | $184.6K | $100.6K | $0 | · | |
| Other Non-current Assets | · | · | · | · | $3.3K | · | · | · | · | · | · | · | |
| Total Assets | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Accounts Payable | $270.7K | $273.5K | $317.3K | $3M | $761.9K | $350.9K | $320.8K | $331.8K | $237.6K | $66.4K | $0 | $10.2K | |
| Accrued Liabilities | $0 | $39.9K | $39.9K | $39.9K | $24.4K | $159.8K | $120.5K | $21.6K | $23.1K | $4.9K | $0 | · | |
| Short-term Debt | · | · | · | · | · | $0 | · | · | · | · | $0 | · | |
| Current Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $453.9K | $100 | $154.0K | |
| Total Liabilities | $284.9K | $327.6K | $371.4K | $3M | $1M | $41M | $9M | $4M | $2M | $480.3K | $100 | $154.0K | |
| Long-term Debt | · | · | · | · | · | · | · | · | $493.2K | · | · | · | |
| Common Stock | $3.1K | $1.7K | $1.4K | $1.4K | $6.3K | $1.5K | $22.5K | $6.0K | $114.8K | $105.0K | $32.0K | $18.1K | |
| Paid-in Capital | $78M | $71M | $70M | $70M | $54M | $22M | $17M | · | · | · | $154.2K | $154.2K | |
| Retained Earnings | $-71M | $-65M | $-59M | $-54M | $-44M | $-62M | $-26M | $-17M | $-3M | $-766.6K | $-500 | $-325.3K | |
| Treasury Stock | $10.0K | $0 | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $8M | $6M | $10M | $16M | $10M | $-40M | $-8M | $-4M | $-2M | $-157.8K | $49.5K | $-153.0K | |
| Liabilities + Equity | $8M | $7M | $11M | $19M | $11M | $717.8K | $530.8K | $477.2K | $203.1K | $322.5K | $49.6K | $954 | |
| Shares Outstanding | 3,696,668 | 1,748,428 | 1,373,626 | 1,407,624 | 6,338,864 | 1,537,074 | 22,489,046 | 6,018,075 | 114,799,226 | 105,013,750 | 32,010,000 | 18,113,750 |
Nakit Akışı 12
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $56.0K | $56.0K | · | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $3.5K | $36.6K | $36.6K | $68.7K | $595.4K | $170.3K | $0 | $1.9K | $144.2K | $2.6K | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Amort. of Intangibles | $123.3K | $110.5K | $94.6K | $92.1K | $92.1K | $66.8K | $26.9K | $21.1K | $16.0K | $9.4K | · | · | |
| Operating Cash Flow | $-6M | $-5M | $-8M | $-8M | $-2M | $-434.6K | $-1M | $-1M | $-889.6K | $-445.2K | $-14.6K | $-17.3K | |
| Investing Cash Flow | $-50.5K | $6M | $3M | $-10M | $0 | $-250.0K | $0 | · | $0 | $-10.0K | $0 | $0 | |
| Stock Issued | $7M | $2M | $0 | $15M | $15M | $0 | · | $0 | $100.0K | $500.0K | · | · | |
| Stock Repurchased | $10.0K | $175.0K | $271.0K | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $100.0K | $500.0K | · | · | |
| Financing Cash Flow | $7M | $1M | $-271.0K | $15M | $13M | $693.9K | $997.7K | $1M | $681.5K | $677.0K | $13.9K | $17.9K | |
| Net Change in Cash | $1M | $2M | · | · | · | $9.4K | $-215.4K | $290.4K | $-208.2K | $221.8K | $-738 | $580 | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 69.2% | 72.5% | · | -66.7% | · | · | · | |
| Operating Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| Net Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | -55398.1% | · | · | · | |
| Pretax Margin | · | · | · | · | · | -22082.2% | -5126.1% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -677.7% | -682.9% | · | -24537.6% | · | · | · | |
| ROA | · | · | · | · | · | -5818.7% | -1683.3% | · | -1011.7% | -411.7% | -5258.3% | -4218.7% | |
| ROE | · | · | · | · | · | 170.6% | 145.8% | · | 222.1% | 1414.8% | 33.5% | 20.2% | |
| ROIC | · | · | · | · | · | 2.8% | 14.0% | · | · | · | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Quick Ratio | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.5 | 0.0 | 0.0 | |
| Interest Coverage | · | · | · | · | · | -0.9 | -0.6 | · | -3.1 | · | · | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.3 | 0.3 | · | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | 58.8 | 21.8 | · | 2.0 | · | · | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -45.5% | 22.2% | -89.8% | 0.96% | -46.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -59.2% | -50.0% | -62.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -48.4% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K | $164.5K | $165.5K | $124.4K | $4.8K | $0 | $0 | $0 | |
| Net Income TTM | $-6M | $-5M | $-5M | $-10M | $19M | $-36M | $-8M | $-14M | $-3M | $-766.1K | $-30.8K | $-28.0K | |
| Market Cap | · | · | · | · | · | $106.83B | $5.06B | · | $1.16T | $40.17T | $149.44B | · | |
| P/E | -0.8 | -0.6 | -1.2 | -4.1 | 3.9 | -2.2 | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | 649401.8 | 30574.2 | · | 242154617.3 | · | · | · | |
| P/B | · | · | · | · | · | -2683.9 | -626.9 | · | -519790.8 | -254563057.3 | -813031.5 | · | |
| P / Tangible Book | 1.0 | 0.7 | 0.6 | 3.5 | 14.5 | · | · | · | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | -245829.3 | -4171.2 | · | -1306558.8 | 90217593.0 | -10208938.2 | · | |
| Earnings Yield | -128.6% | -160.6% | -81.6% | -24.4% | 25.4% | -45.1% | · | · | · | · | · | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $3.0K | $0 | $0 | $3.0K | $3.0K | $0 | $8.0K | $0 | $3.0K | $6.0K | $0 | $0 | $18.6K | $55.0K | |
| Cost of Revenue | $0 | $0 | $994 | $0 | $0 | $1.2K | $1.2K | $0 | $3.2K | $0 | $1.2K | $2.4K | $0 | $0 | $5.7K | $16.0K | |
| Gross Profit | $0 | $0 | $2.0K | $0 | $0 | $1.8K | $1.8K | $0 | $4.8K | $0 | $1.8K | $3.6K | $0 | $0 | $12.9K | $39.0K | |
| R&D Expense | $459.2K | $541.7K | $550.1K | $465.2K | $501.3K | $743.3K | $471.8K | $581.8K | $924.7K | $422.4K | $349.4K | $992.7K | $309.5K | $319.0K | $5M | $230.9K | |
| SG&A Expense | $1M | $888.6K | $1M | $776.8K | $731.5K | $888.4K | $1M | $498.6K | $676.1K | $671.5K | $1M | $531.0K | $859.5K | $771.0K | $899.6K | $805.5K | |
| Operating Expenses | $2M | $1M | $2M | $1M | $1M | $2M | $2M | $1M | $2M | $1M | $2M | $2M | $1M | $1M | $6M | $1M | |
| Operating Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-2M | $-1M | $-1M | $-6M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $50 | · | $0 | |
| Other Non-op | $50.9K | $55.4K | $58.1K | $37.1K | $30.2K | $22.4K | $31.7K | $69.5K | $67.6K | $81.6K | $93.3K | $89.2K | $89.9K | $61.1K | $62.2K | $38.1K | |
| Pretax Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-2M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-1M | $-2M | $-1M | $-2M | $-1M | $-1M | $-1M | $-6M | $-982.3K | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.07 | |
| EPS (Diluted) | $-0.41 | $-0.38 | $-2.39 | $-0.48 | $-0.48 | $-0.83 | $-2.58 | $-0.75 | $-1.11 | $0.73 | · | · | · | · | · | $-0.07 | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 14,068,412 | |
| Shares (Diluted) | 3,701,668 | 3,701,668 | -4,759,002 | 2,580,532 | 2,580,532 | 1,980,735 | -2,738,511 | 1,392,284 | 1,405,208 | 1,421,439 | · | · | · | · | · | 14,068,412 | |
| EBITDA | $-2M | $-1M | · | $-1M | $-1M | $-2M | · | $-1M | $-2M | $-1M | · | $-2M | $-1M | $-1M | · | $-1M |
Bilanço 18
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | $5M | $4M | $10M | $8M | $17M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Inventory | $125.0K | $125.0K | $0 | $994 | $994 | $994 | $2.2K | $3.4K | $3.4K | $6.6K | $6.6K | $7.8K | $10.2K | $10.2K | $10.2K | $15.9K | |
| Prepaid Expense | $70.5K | $105.0K | $138.8K | $35.0K | $87.6K | $140.2K | $192.7K | $67.6K | $129.1K | $190.6K | $277.2K | $61.5K | $153.7K | $245.9K | $338.1K | · | |
| Current Assets | $9M | $6M | $7M | $5M | $7M | $8M | $6M | $6M | $8M | $9M | $10M | $12M | $14M | $15M | $19M | $22M | |
| Intangibles | $355.5K | $378.4K | $407.2K | $438.2K | $469.2K | $500.0K | $530.6K | $553.2K | $382.5K | $411.7K | $441.0K | $466.5K | $389.6K | $412.6K | $435.6K | $458.6K | |
| Total Assets | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Accounts Payable | $684.4K | $293.5K | $270.7K | $247.2K | $263.4K | $272.2K | $273.5K | $273.8K | $322.2K | $336.8K | $317.3K | $367.0K | $344.4K | $353.4K | $3M | $327.8K | |
| Accrued Liabilities | · | · | $0 | $0 | $0 | $0 | $39.9K | $42.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $39.9K | $54.9K | |
| Current Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | $397.0K | |
| Total Liabilities | $698.6K | $307.6K | $284.9K | $261.4K | $277.6K | $286.4K | $327.6K | $330.9K | $376.3K | $391.0K | $371.4K | $421.2K | $398.5K | $407.5K | $3M | · | |
| Common Stock | $6.5K | $3.1K | $3.1K | $2.6K | $2.6K | $2.6K | $1.7K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $14.1K | $1.4K | $14.1K | |
| Paid-in Capital | $82M | $78M | $78M | $74M | $74M | $74M | $71M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | $70M | |
| Retained Earnings | $-74M | $-72M | $-71M | $-69M | $-67M | $-66M | $-65M | $-63M | $-62M | $-60M | $-59M | $-57M | $-56M | $-55M | $-54M | $-48M | |
| Treasury Stock | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $0 | $445.9K | $420.5K | $353.7K | $271.0K | $191.8K | · | · | $0 | · | |
| Stockholders' Equity | $9M | $6M | $8M | $6M | $7M | $8M | $6M | $7M | $8M | $9M | $10M | $12M | $14M | $15M | $16M | $22M | |
| Liabilities + Equity | $9M | $6M | $8M | $6M | $7M | $8M | $7M | $7M | $8M | $10M | $11M | $13M | $14M | $15M | $19M | $22M | |
| Shares Outstanding | 6,492,008 | 3,696,668 | 3,696,668 | 2,580,532 | 2,580,532 | 2,580,532 | 1,748,428 | 1,329,876 | 1,338,126 | 1,354,626 | 1,373,626 | 1,391,126 | 1,431,126 | 14,076,238 | 1,407,624 | 14,076,238 |
Nakit Akışı 11
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $46.0K | · | $0 | $0 | $46.0K | · | · | · | · | · | $0 | |
| Stock-based Comp | $0 | $0 | $0 | $0 | $0 | $3.5K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | $9.2K | |
| Amort. of Intangibles | $22.9K | $28.9K | $30.9K | $31.1K | $30.7K | $30.6K | $22.6K | $29.3K | $29.3K | $29.3K | $25.5K | $23.0K | $23.0K | $23.0K | $23.0K | $23.0K | |
| Operating Cash Flow | $-1M | $-1M | $-2M | $-1M | $-1M | $-2M | $-2M | $-985.6K | $-1M | $-896.9K | $-2M | $-1M | $-986.7K | $-4M | $-4M | $-873.3K | |
| Investing Cash Flow | $0 | $-175.0K | $-50.5K | $0 | $0 | $0 | $0 | $-200.0K | $0 | $7M | $933.9K | $2M | $-5M | $5M | $-5M | $-5M | |
| Stock Issued | $4M | $0 | · | · | $0 | $3M | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $10.0K | $0 | $25.4K | $66.7K | $82.8K | $79.2K | $191.8K | $0 | $0 | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-10.0K | · | · | · | $-82.8K | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $13.4K | $4M | $0 | $0 | $3M | $2M | $-25.4K | $-66.6K | $-82.8K | $-79.2K | $-191.8K | $0 | $0 | $0 | $12 | |
| Net Change in Cash | $3M | $-1M | · | · | $-1M | $2M | · | · | · | · | · | · | · | · | · | · | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 60.0% | · | · | 60.0% | · | · | 60.0% | · | · | · | 70.9% | |
| Operating Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| Net Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| Pretax Margin | · | · | · | · | · | -54603.2% | · | · | -19471.6% | · | · | -24232.5% | · | · | · | -1786.1% | |
| EBITDA Margin | · | · | · | · | · | -55349.3% | · | · | -20316.3% | · | · | -25719.8% | · | · | · | -1855.3% | |
| ROA | -18.4% | -19.0% | · | -19.4% | -16.3% | -18.2% | · | -10.7% | -14.1% | -8.4% | · | -8.3% | -5.9% | -8.4% | · | -7.7% | |
| ROE | -19.5% | -19.8% | · | -20.3% | -17.1% | -18.9% | · | -11.2% | -14.6% | -8.7% | · | -8.5% | -6.0% | -8.7% | · | -9.0% | |
| ROIC | -18.1% | -23.9% | · | -22.8% | -18.5% | -20.6% | · | · | -21.3% | -12.2% | · | -12.8% | -8.7% | -7.5% | · | -4.6% |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.9 | 19.7 | · | 20.7 | 23.9 | 27.4 | · | 19.1 | 20.2 | 23.5 | · | 28.6 | 34.5 | 36.3 | · | 55.4 | |
| Quick Ratio | · | · | · | · | · | · | · | · | · | · | · | 10.7 | 10.0 | 23.4 | · | 42.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | · | · | -22261.4 | · | · |
Verimlilik 2
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.5 | 0.0 | · | 0.2 | 0.0 | 0.0 | · | 2.0 |
Değerleme (TTM) 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $3.0K | · | $3.0K | $11.0K | $11.0K | · | $14.0K | $14.0K | $6.0K | · | $61.0K | $55.0K | $70.0K | · | $80.0K | |
| Net Income TTM | $-5M | $-6M | · | $-5M | $-5M | $-5M | · | $-5M | $-5M | $-5M | · | $-5M | $-5M | $-5M | · | $-6M | |
| Market Cap | $9M | $8M | · | $9M | $7M | $6M | · | $4M | $5M | $7M | · | $7M | $7M | $70M | · | $62M | |
| P/E | -0.8 | -0.9 | · | -3.8 | -1.8 | -7.2 | · | · | · | · | · | -4.1 | -3.9 | -4.2 | · | -3.7 | |
| P/S | · | 2538.4 | · | 2864.4 | 621.7 | 509.1 | · | 294.5 | 368.0 | 1176.3 | · | 112.2 | 120.6 | 1005.4 | · | 774.2 | |
| P/B | 1.1 | 1.2 | · | 1.5 | 1.0 | 0.7 | · | 0.6 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.7 | · | 2.8 | |
| P / Tangible Book | 1.1 | 1.3 | · | 1.7 | 1.1 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.5 | 4.9 | · | 2.9 | |
| P / Cash Flow | · | -5.8 | · | · | · | -3.5 | · | · | · | -7.9 | · | · | · | -18.3 | · | · | |
| Earnings Yield | -120.7% | -105.3% | · | -26.4% | -57.0% | -13.8% | · | · | · | · | · | -24.4% | -25.9% | -24.0% | · | -27.3% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $6.0K | $11.0K | $9.0K | $88.6K | $87.8K |
| Net Gelir | $-6M | $-5M | $-5M | $-10M | $19M |
| Seyreltilmiş Hisse Başı Kâr | $-2.52 | $-3.71 | $-3.76 | $-0.93 | $5.61 |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 17 dosya · $546K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 8 (+2 önceki Ç'ye göre) | 3 (-2 önceki Ç'ye göre) | 4 (+2 önceki Ç'ye göre) | 3 (+1 önceki Ç'ye göre) | +274K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Hudson Bay Capital Management LP | $195.997 | 135.170 | 35,87% | Hisse senetleri |
| Anson Funds Management LP | $153.046 | 105.549 | 28,01% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $60.900 | 42.000 | 11,15% | Hisse senetleri |
| XTX Topco Ltd | $38.511 | 26.559 | 7,05% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $35.269 | 24.316 | 6,45% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.508 | 20.350 | 5,40% | Hisse senetleri |
| VANGUARD GROUP INC | $10.815 | 5.518 | 1,98% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $8.001 | 5.518 | 1,46% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $7.037 | 4.853 | 1,29% | Hisse senetleri |
| Global Retirement Partners, LLC | $5.971 | 4.118 | 1,09% | Hisse senetleri |
| MORGAN STANLEY | $745 | 514 | 0,14% | Hisse senetleri |
| HARBOUR INVESTMENTS, INC. | $325 | 224 | 0,06% | Hisse senetleri |
| Bogart Wealth, LLC | $145 | 100 | 0,03% | Hisse senetleri |
| BARCLAYS PLC | $78 | 54 | 0,01% | Hisse senetleri |
| SBI Securities Co., Ltd. | $62 | 43 | 0,01% | Hisse senetleri |
| UBS Group AG | $22 | 15 | 0,00% | Hisse senetleri |
| Motiv8 Investments LLC | $0 | 1 | 0,00% | Hisse senetleri |
Şirket yöneticileri 2 içeriden öğrenenler · 1 yöneticiler · 1 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Timothy Warbington | President & CEO | 03 Haziran 2020 J | 26.503.334 | 0 | 0 | $0 |
| CREATIVE MEDICAL HEALTH INC. | 10% sahip | 03 Haziran 2020 J | 26.503.334 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Timothy Warbington, Creative Medical Health, Inc. ×5 başvurular | 18 Ekim 2018 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Temmuz 2026 | Günlük |